Strode Quoted on Pfizer Deal to Buy Hospira

05 February 2015 Chicago Tribune News

Chicago Tribune

Partner Roger Strode was quoted in a Chicago Tribune article, “Hospira Stock Soars as Pfizer Says it will Buy for $15.23 Billion,” on February 5, 2015. The article discussed details surrounding pharmaceutical giant Pfizer’s plans to buy Illinois drug maker Hospira. Strode was quoted saying, “The shareholders of Hospira are going to be really well off. Hospira’s stock has zoomed already. It’s a huge benefit to them.”

Strode also touched on the outlook for mergers and acquisitions in the pharmaceutical industry and said, “Pharma has been very robust. A lot of companies have done well and they’re sitting on a lot of cash. We’re still in the middle of a bull market.”

Related Services


ERISA/Cybersecurity Considerations in the COVID Age
21 October 2020
Privacy, Cybersecurity & Technology Law Perspectives
A Review of Recent Whistleblower Developments
21 October 2020
Legal News: Whistleblower Developments
U.S. EPA Formalizes Reversal of “Once In/Always In” Emission Permitting Policy
21 October 2020
Legal News: Environmental
Georgia Finalizes New Telemedicine Practice Rules
21 October 2020
Health Care Law Today
Discover Telehealth Conference
18 November 2020
ACI’s Proficiency Series on Rx Drug Pricing and Rebate Fundamentals
17-19 November 2020
2020 NDI Reimagined
11-13 November 2020
Foley’s Annual Government Contracts Update
10 November 2020